Hossein Nazari, MD

Hossein Nazari

Contact Info

MD, Zanjan University of Medical Sciences, Zanjan, Iran, 1998

Residency in Ophthalmology, UTMB, Galveston, Texas, 2019

Residency in Ophthalmology, Tabriz University of Medical Sciences, Tabriz, Iran, 2004

Vitreoretinal Surgery Fellowship, University of Minnesota, Minneapolis, MN 2020

Vitreoretinal Surgery Fellowship: Iran University of Medical Sciences *IUMS), Tehran, Iran



Dr. Nazari treats patients with simple and complex vitreoretinal issues such as macular degeneration, diabetic retinal diseases, retinal detachment and retinal holes, inherited retinal diseases, and retinopathy of prematurity.

Awards & Recognition

Rapid Response Grant, University of Minnesota; 2020
Fellowship research award: University of Minnesota; 2020
Surgical Video presentation, Vit-Buckle Society annual meeting; 2020
Research Scholarship Award, UTMB Ophthalmology Residency Program; 2019
Silver Scalpel Award; UTMB Ophthalmology Residency Program; 2019
Academic Achievement Award, UTMB Ophthalmology Residency Program; 2019
Academic Achievement Award; UTMB Ophthalmology Residency Program; 2018
Academic Achievement Award; UTMB Ophthalmology Residency Program; 2017
First presentation award, Sun and Science: National Eye Resident Research Conference, UTMB, 2016
National Institute of Health (NEI)/Association for Research in Vision and Ophthalmology (ARVO) travel award, ARVO annual meeting 2014
Doheny Eye Institute Basic Science Award, 2013
California Institute for Regenerative Medicine (CIRM) training award for stem cell research 2012




Tai Y, Scianmarello N, Kang D, Park J, Humayun M, Murali K, Kashani A, Nazari Khanamiri H; Small molecular transport device for drug delivery or waste removal. USPTO # 9655774 B2. 2017

Papers in peer reviewed journals:

Nazari H, Ivannikov M, Ochoa L, Vargas G, Motamedi M. Microsurgical Dissection and Tissue Clearing for High Resolution Intact Whole Retina and Vitreous Imaging. J Vis Exp. 2020 [accepted]

Nakatsuka A, Nazari H, Merkley K. Fishhook injury of the anterior chamber angle of the eye. Hawai’I Journal of Medicine and public Health. 2019 Jun; 78 (6):200-201

Nakatsuka A, Nazari H, Lam Q, El Annan J. Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature. Hawai’i Journal of Medicine and Public Health. 2019 May; 78(5): 151-154 kk

Nazari H, Nakatsuka A, Soliman M. Optic Nerve Head Elevation in an Asymptomatic Child: Worry or Watch? Pediatr Neurol. 2018 May;82:55-56

Sadaka A, Iqbal C, Nazari H, et al. Positive visual phenomena following the Argus II Retinal Prosthesis implantation. Ophthalmic Surg Lasers Imaging Retina 2017 Dec 1; 48 (12): 1022-1025

Nazari H, Kim-Binh M, Yalamanchili S, Chang E. Metallic Filament Embolization of the Retinal Artery. JAMA Ophthalmol. 2017 Nov 1;135(11):1279-1281

Nazari H, Falabella P, Yue L, Weiland J, Humayun M. Retinal Prostheses. Journal of Vitreoretinal Diseases 2017. 1-10

Nazari H, Nakatsuka A, El Annan J. Smartphone fundus photography. J Vis Exp. 2017 Jul 6;(125).

Thomas B, Zhu L, Zhang L, Thomas PB, Nazari H, et al. Survival and Functionality of hESC Derived Retinal Pigment Epithelium Cells Cultured as a Monolayer on Polymer Substrates Transplanted in RCS Rats. IOVS 2016; 57 (6):2877-87

Murali K, Kang D, Nazari H, et al. Spatial Variations in Vitreous Oxygen Consumption. PLoS One. 2016 Mar 1;11(3):e0149961.

Ishikawa K, Sreekumar PG, Spee C, Nazari H, et al. ?B-crystallin regulates subretinal fibrosis by modulation of epithelial-mesenchymal transition. AJP 2016; 1864):859-73

Abri Aghdam K, Joshaghani M, Nazari H, et al. Comparison of the effect of cycloplegic versus NSAID eye drops on pain after photorefractive keratectomy. J Curr Ophthalmol 2016. 27 (3-4):87-91

Roybal CN, Sanfilippo CJ, Nazari H, et al. Multimodal imaging of the retinal and choroid in systemic amyloidosis. Retin Cases Brief Rep. 2015;9(4):339-46.

He S, Barron E, Ishikawa K, Nazari H, et al. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5579-89

Ghasemi Falavarjani K, Nazari Khanamiri H, et al. Determination of the toxicity of intravitreal minocycline in rabbit eyes. Cutaneous and Ocular Toxicology 2016;35(3):233-6.

Nazari H, Zhang L, et al. Stem cell based therapies for age-related macular degeneration: The promises and the challenges. Prog Retin Eye Res. 2015; 48:1-39

Olmos L, Nazari H, Rodger D, Humayun M. Stem Cell Therapy for the Treatment of Dry Age-Related Macular Degeneration. Current Ophthalmology Reports 2015;

Hirsch L, Nazari H, Sreekumar PG, Kannan R, Dustin L, Zhu D, Barron E, Hinton DR. TGF-?2 secretion from RPE decreases with polarization and becomes apically oriented. Cytokine. 2015;71(2):394-6

Ishikawa K, He S, Terasaki H, Nazari H, et al. Resveratrol inhibits epithelial-to-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Sci Rep 2015; 5: 16386

Naseripour M, Jaberi R, Sedaghat A, Azma Z, Nojomi M, Falavarjani KG, Nazari H. Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate. J Contemp Brachytherapy. 2016 Feb;8(1):66-73.

Askari M, Nikpoor AR, Nazari H, et al. Association of Apolipoprotein E Alleles with Susceptibility to Age-Related Macular Degeneration in Iranian Patients. Research in Molecular Medicine 2015; (3) 2:22-27.

Askari M, Nikpoor AR, Nazari H, et al. Association of Htra1 gene polymorphisms with the risk of developing AMD in Iranian population. Rep Biochem Mol Biol. 2015 Oct;4(1):43-9.

Nazari H, Karakousis P, Rao N. Replication of Mycobacterium tuberculosis in Retinal Pigment Epithelium. JAMA Ophthalmol 2014 June;132(6):724-9. PMID: 24723139

Nazari H, Ghasemi Falavarjani K, Sanati MH, Aryan A, Irani A, Hashemi M, Modarres M, Parvaresh MM, Nikeghbali A. Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran. Journal of Ophthalmic and Vision Research 2014;9(2):181-7.

Nazari H, Hariri A, Hu Z, et al. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: In vivo documentation. J Ophthalmic Inflamm Infect. 2014 Mar 22;4(1):9.

Parvaresh MM, Ghasemi Falavarjani K, Modarres M, Nazari H, Saiepour N. Transscleral Diode Laser Photocoagulation for Type 1 Prethreshold Retinopathy of Prematurity. Journal of Ophthalmic and Vision Research 2013; 8 (4):298-302.

Hong B, Nazari Khanamiri H, Rao N. The Role of Ultra-Widefield Fluorescein Angiography in the Management of Uveitis. Can J Ophthalmol 2013 Dec;48(6):489-93.

Nazari H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Survey of Ophthalmology. 2013;58(3):203-32.

Nazari H, Dustin L, Heussen FM, Sadda SV, Rao N. Morphometric analysis of optical coherence tomography predicts visual outcome in uveitis patients with epiretinal membrane. American Journal of Ophthalmology 2012 Jul: 154(1):78-86.

Nazari H, Rao NA. Antitubercular therapy is not required in latent tuberculosis. Br J Ophthalmol 2012;96(3):463.

Nazari H, Rao NA. Longitudinal morphometric analysis of epiretinal membrane in patients with uveitis. Ocular Immunology and inflammation 2013;21(1):2-7.

Nazari H, Rao NA. Resolution of subretinal fluid with systemic corticosteroids treatment in acute Vogt-Koyanagi-Harada Disease. Br J Ophthalmol 2012;96(11):1410-4

Tayil S, Albini T, Nazari H, Moshfeghi AA, Parel JM, Rao NA, Karakousis PC. Local ischemia and increased expression of vascular endothelial growth factor following ocular dissemination of mycobacterium tuberculosis. PLoS ONE, 2011;6(12):e28383.

Ghasemi Falavarjani K, Hashemi M, Jalili Fazel A, Modarres M, Nazari H, Parvaresh M. Pars Plana vitrectomy and intravitreal phacoemulsification for Dropped Nuclei. J Ophthalmic Vis Res. 2012; 7 (2): 125-129.

Nazari H, Nilforushan N, Sedaghat A, Soudi R, Irani A, Gordiz, A, Hatamkhani S. Intraocular pressure after exposure to moderate altitude. Graefes Archives for Clinical and Experimental Ophthalmology 2013;251(1):123-7.

Joshaghani M, Nazari H, Ghasemi Falavarjani K, et al. Effect of Homatropine eye drops on pain after photorefractive keratectomy; a pilot study. Saudi Journal of Ophthalmology 2013;27(2):83-87.

M Naroi Nejad, M Yousefi, Nazari H, A Ghasempoor. Comparing carotid intima-media thickness in type 2 diabetes between patients with and without retinopathy. Tehran University Medical Journal (TUMJ) 2012; 70 (3):150-155.

Modarres M, Nazari H, Rezaei Kanavi M, et al. Determination of safety of escalating doses of Intravitreal Erythropoietin in Rabbit Eyes. Iranian Journal of Ophthalmology. 2012;24(2):26-32.

Nazari H, SM Modareszadeh, R Soudi, A Maleki, H Mirzajani. A review article of pharmacologic vitreolysis. Razi Journal of Medical Sciences 18 (82), 32-43

Modarres M, Falavarjani KG, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2011;95(7):992-5.

Nazari H, Modarres M, Parvaresh MM, Ghasemi Falavarjani K. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage; Graefe's Archive for Clinical and Experimental Ophthalmology 2010;248(12):1713-8.

Nazari H, Moddares M, Maleki A; Pharmacologic vitreolysis. J Ophthalmic Vis Res 2010; 5 (1): 44-52.

Falavarjani KG, Modarres M, Nazari H, Naseripour M, Parvaresh MM. Diabetic macular edema following panretinal photocoagulation. Arch Ophthalmol. 2010;128(2):262.

Nazari H. Laser prophylaxis for peripheral retinal lesions. Lasers in Medicine 2009; 6(3): 29-34.

Modarres M, Nazari H, Falavarjani KG, et al. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2009;19(5): 848 – 852.

Razpa E, Nazari H, et al. Prevalence of head and neck abnormalities among people with consanguineous parents. Tehran University Medical Journal 2008; 66: 515-520.

Falavarjani KG, Modarres M, Nazari H. Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy. Eye. 2010;24(4):717-719.

Nazari H, Modarres M, Naseripour M, et al. Central retinal artery perfusion following 0.1 ml intravitreal injection of Bevacizumab. Iranian J Ophthalmol 2009;21(2): 13-18.

Naseripour M, Nazari H, Bakhtiari P, et al. Ruthenium-106 plaque radiotherapy for retinal vasoproliferative tumors. Iranian J Ophthalmol 2009;21:31-35.

Naseripour M, Nazari H, Bakhtiari P, et al. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol 2009;93(1):28-32.

Mohammadreza H, Nazari H, et al. Measurement of Choroidal Neovascular Area in Age-Related Macular Degeneration using Modified Otsu’s Thresholding Method; Iranian J Med Phys 2008; 20,21: 77-84.

Naseripour M, Nazari H, Bakhtiari P, et al. Outcomes and prognosis of treatment for retinoblastoma with primary chemotherapy and focal treatment. Bina J Ophthalmol 2008;14(1):3-9.

Nabei R, Nazari H. Okihiro syndrome: A Duane’s syndrome variant. Bina J Ophthalmol 2004;10(1):55-59.

Book chapters:

“Recent Advances in Ocular Imaging in Management of Uveitis and Related Intraocular Inflammations” Nazari H, Rao N. In “Advances in Ophthalmology and Optometry” Edited by Myron Yanoff; p435–457 ; 2017; Elsevier

“Artificial Vision” Weiland J, Nazari H, Humayun H. in “Ryan’s Retina” 6th edition. 2017 Elsevier

“Argus II Retinal Prosthesis System”. Falabella P, Nazari H. Weiland J, Humayun M. in “Artificial Vision, a clinical guide”. Springer. 2017

“Scaffolds for Cell Transplantation” George M, Nazari H, Mitra D, Clegg D, Hinton D, Humayun M. In “Cellular Therapies for Retinal Disease” edited by Schwartz, Nagiel, Lanza; P: 45-54; Springer

“Multifocal Choroiditis/Serpiginous Choroiditis and Related Entities” Nazari H, Rao N. in “Advances in Intraocular Inflammation Imaging and Treatment” edited by Narsing Rao and Damien Rodger, and Julie Schallhorn; Springer 2019